Institute of Information and Communication Technologies (ITACA)

The importance of not trivialising the Covid19 pandemic

Do not miss this lecture by the renowned epidemiology expert Daniel López-Acuña

Under the title “The importance of not trivialising the Covid19 pandemic: Lessons we should learn to adapt better to what is coming“, the renowned epidemiology expert Daniel López-Acuña will give a talk on Thursday, 1 June at 19:00 at the Polytechnic City of Innovation of the Universitat Politècnica de València (UPV). The event is in collaboration with the Fisabio Foundation and is part of the Medicarama Chair in Technology and Health.

The lecture will address issues of vital relevance. While some may consider the Covid19 crisis to be a thing of the past, studies indicate that we will face new challenges in the near future. In this context, it is crucial to ask ourselves fundamental questions: Are we adequately prepared? What have we learned so far? Will we persist in repeating the same mistakes?

These questions, among others, will be the subject of an enriching debate in the framework of this lecture, in which Daniel López-Acuña will share his vast knowledge. His ability to communicate and transmit information clearly and accurately has been evidenced in several television interventions during and after the pandemic.

The event is open to the public, although it is important to note that capacity is limited. It is therefore recommended that you arrive well in advance to guarantee a place. Take advantage of this valuable opportunity to learn from one of the leading epidemiology experts and reflect on how we can adapt more effectively to the challenges ahead.

If you are unable to attend, you can also follow it online. To do so, you must register here. You will receive an invitation from Zoom to connect.

Recent News

Leading innovation at the UPV since 1999

More than 1000 research projects, with a total amount of more than 100 million euros; 1500 papers in prestigious scientific journals and more than 2000 contributions to international congresses; 50 patents and 5 spin-offs/start-ups.